Xu Q - Search Results

1

Knockout of beta(1)- and beta(2)-adrenoceptors attenuates pressure overload-induced cardiac hypertrophy and fibrosis.

Kiriazis H, Wang K, Xu Q, Gao XM, Ming Z, Su Y, Moore XL, Lambert G, Gibbs ME, Dart AM, Du XJ. Kiriazis H, et al. Among authors: xu q. Br J Pharmacol. 2008 Feb;153(4):684-92. doi: 10.1038/sj.bjp.0707622. Epub 2008 Jan 14. Br J Pharmacol. 2008. PMID: 18193078 Free PMC article.

2

Myocardial oxidative stress contributes to transgenic β₂-adrenoceptor activation-induced cardiomyopathy and heart failure.

Xu Q, Dalic A, Fang L, Kiriazis H, Ritchie RH, Sim K, Gao XM, Drummond G, Sarwar M, Zhang YY, Dart AM, Du XJ. Xu Q, et al. Br J Pharmacol. 2011 Mar;162(5):1012-28. doi: 10.1111/j.1476-5381.2010.01043.x. Br J Pharmacol. 2011. PMID: 20955367 Free PMC article.

3

Optimizing dosage of ketamine and xylazine in murine echocardiography.

Xu Q, Ming Z, Dart AM, Du XJ. Xu Q, et al. Clin Exp Pharmacol Physiol. 2007 May-Jun;34(5-6):499-507. doi: 10.1111/j.1440-1681.2007.04601.x. Clin Exp Pharmacol Physiol. 2007. PMID: 17439422

4

Endogenous relaxin does not affect chronic pressure overload-induced cardiac hypertrophy and fibrosis.

Xu Q, Lekgabe ED, Gao XM, Ming Z, Tregear GW, Dart AM, Bathgate RA, Samuel CS, Du XJ. Xu Q, et al. Endocrinology. 2008 Feb;149(2):476-82. doi: 10.1210/en.2007-1220. Epub 2007 Nov 8. Endocrinology. 2008. PMID: 17991721

5

Chronic activation of the low affinity site of β1-adrenoceptors stimulates haemodynamics but exacerbates pressure-overload cardiac remodelling.

Kiriazis H, Tugiono N, Xu Q, Gao XM, Jennings NL, Ming Z, Su Y, Klenowski P, Summers RJ, Kaumann A, Molenaar P, Du XJ. Kiriazis H, et al. Among authors: xu q. Br J Pharmacol. 2013 Sep;170(2):352-65. doi: 10.1111/bph.12272. Br J Pharmacol. 2013. PMID: 23750586 Free PMC article.

6

Infarct size and post-infarct inflammation determine the risk of cardiac rupture in mice.

Gao XM, Ming Z, Su Y, Fang L, Kiriazis H, Xu Q, Dart AM, Du XJ. Gao XM, et al. Among authors: xu q. Int J Cardiol. 2010 Aug 6;143(1):20-8. doi: 10.1016/j.ijcard.2009.01.019. Epub 2009 Feb 4. Int J Cardiol. 2010. PMID: 19195725

7

Reversal of cardiac fibrosis and related dysfunction by relaxin.

Du XJ, Xu Q, Lekgabe E, Gao XM, Kiriazis H, Moore XL, Dart AM, Tregear GW, Bathgate RA, Samuel CS. Du XJ, et al. Among authors: xu q. Ann N Y Acad Sci. 2009 Apr;1160:278-84. doi: 10.1111/j.1749-6632.2008.03780.x. Ann N Y Acad Sci. 2009. PMID: 19416203

8

Arginase II knockout mouse displays a hypertensive phenotype despite a decreased vasoconstrictory profile.

Huynh NN, Andrews KL, Head GA, Khong SM, Mayorov DN, Murphy AJ, Lambert G, Kiriazis H, Xu Q, Du XJ, Chin-Dusting JP. Huynh NN, et al. Among authors: xu q. Hypertension. 2009 Aug;54(2):294-301. doi: 10.1161/HYPERTENSIONAHA.108.121731. Epub 2009 Jun 22. Hypertension. 2009. PMID: 19546381

9

Deletion of macrophage migration inhibitory factor protects the heart from severe ischemia-reperfusion injury: a predominant role of anti-inflammation.

Gao XM, Liu Y, White D, Su Y, Drew BG, Bruce CR, Kiriazis H, Xu Q, Jennings N, Bobik A, Febbraio MA, Kingwell BA, Bucala R, Fingerle-Rowson G, Dart AM, Morand EF, Du XJ. Gao XM, et al. Among authors: xu q. J Mol Cell Cardiol. 2011 Jun;50(6):991-9. doi: 10.1016/j.yjmcc.2010.12.022. Epub 2011 Jan 6. J Mol Cell Cardiol. 2011. PMID: 21215754

10

Pathological hypertrophy reverses β2-adrenergic receptor-induced angiogenesis in mouse heart.

Xu Q, Jennings NL, Sim K, Chang L, Gao XM, Kiriazis H, Lee YY, Nguyen MN, Woodcock EA, Zhang YY, El-Osta A, Dart AM, Du XJ. Xu Q, et al. Physiol Rep. 2015 Mar;3(3):e12340. doi: 10.14814/phy2.12340. Physiol Rep. 2015. PMID: 25780088 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18,666 results

Search Page